Dupont Capital Management Corp Horizon Therapeutics Public LTD CO Transaction History

Dupont Capital Management Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	BUY	$107.32 - $113.5 $3.47 Million - $3.67 Million	32,350 Added 81.18%	72,200 $7.88 Million
Q4 2022 Jan 26, 2023	BUY	$62.39 - $113.8 $1.64 Million - $2.99 Million	26,265 Added 193.34%	39,850 $0
Q3 2022 Oct 31, 2022	SELL	$58.92 - $84.67 $473,540 - $680,492	-8,037 Reduced 37.17%	13,585 $841,000
Q2 2022 Jul 26, 2022	BUY	$79.4 - $116.36 $495,376 - $725,970	6,239 Added 40.56%	21,622 $1.73 Million
Q1 2022 Apr 27, 2022	BUY	$86.42 - $109.81 $596,557 - $758,018	6,903 Added 81.4%	15,383 $1.62 Million
Q4 2021 Jan 31, 2022	SELL	$98.56 - $119.91 $147,347 - $179,265	-1,495 Reduced 14.99%	8,480 $914,000
Q3 2021 Nov 03, 2021	BUY	$91.91 - $110.37 $741,346 - $890,244	8,066 Added 422.52%	9,975 $1.09 Million
Q2 2021 Jul 30, 2021	BUY	$86.24 - $95.92 $164,632 - $183,111	1,909 New	1,909 $179,000
Q3 2019 Oct 28, 2019	SELL	$23.0 - $27.97 $532,082 - $647,057	-23,134 Closed	0 $0
Q2 2019 Jul 30, 2019	BUY	$22.81 - $28.48 $527,686 - $658,856	23,134 New	23,134 $557,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.